NO20053959L - Medikament omfattende hoy-aktiv langtidsvarende beta-2-aqonist i kombinasjon med andre aktive bestanddeler - Google Patents

Medikament omfattende hoy-aktiv langtidsvarende beta-2-aqonist i kombinasjon med andre aktive bestanddeler

Info

Publication number
NO20053959L
NO20053959L NO20053959A NO20053959A NO20053959L NO 20053959 L NO20053959 L NO 20053959L NO 20053959 A NO20053959 A NO 20053959A NO 20053959 A NO20053959 A NO 20053959A NO 20053959 L NO20053959 L NO 20053959L
Authority
NO
Norway
Prior art keywords
active ingredients
combination
active
aqonist
medication
Prior art date
Application number
NO20053959A
Other languages
English (en)
Norwegian (no)
Other versions
NO20053959D0 (no
Inventor
Roberta Razzetti
Fiorella Pastore
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32748803&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20053959(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of NO20053959D0 publication Critical patent/NO20053959D0/no
Publication of NO20053959L publication Critical patent/NO20053959L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20053959A 2003-02-27 2005-08-25 Medikament omfattende hoy-aktiv langtidsvarende beta-2-aqonist i kombinasjon med andre aktive bestanddeler NO20053959L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03004184A EP1452179A1 (en) 2003-02-27 2003-02-27 Novel medicament combination of a highly potent long-lasting beta2-agonist and a corticosteroid
PCT/EP2004/001960 WO2004075896A1 (en) 2003-02-27 2004-02-27 Medicament comprising a highly potent long-lasting beta2-agonist in combination with other active ingredients

Publications (2)

Publication Number Publication Date
NO20053959D0 NO20053959D0 (no) 2005-08-25
NO20053959L true NO20053959L (no) 2005-11-28

Family

ID=32748803

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20053959A NO20053959L (no) 2003-02-27 2005-08-25 Medikament omfattende hoy-aktiv langtidsvarende beta-2-aqonist i kombinasjon med andre aktive bestanddeler

Country Status (32)

Country Link
US (1) US20070020190A1 (sr)
EP (3) EP1452179A1 (sr)
JP (1) JP2006519204A (sr)
KR (1) KR20050104367A (sr)
CN (2) CN101244063A (sr)
AR (1) AR043419A1 (sr)
AT (1) ATE401887T1 (sr)
AU (1) AU2004216472B2 (sr)
BR (1) BRPI0408047A (sr)
CA (1) CA2517321A1 (sr)
CY (1) CY1108360T1 (sr)
DE (1) DE602004015260D1 (sr)
DK (1) DK1603565T3 (sr)
EA (1) EA008828B1 (sr)
ES (1) ES2309503T3 (sr)
HK (1) HK1087009A1 (sr)
HR (1) HRP20050726A2 (sr)
MA (1) MA27630A1 (sr)
ME (1) MEP32208A (sr)
MX (1) MXPA05009007A (sr)
NO (1) NO20053959L (sr)
NZ (1) NZ541997A (sr)
PE (1) PE20050290A1 (sr)
PL (1) PL377814A1 (sr)
PT (1) PT1603565E (sr)
RS (1) RS20050615A (sr)
SA (1) SA04250122B1 (sr)
SI (1) SI1603565T1 (sr)
TN (1) TNSN05186A1 (sr)
UA (1) UA82217C2 (sr)
WO (1) WO2004075896A1 (sr)
ZA (1) ZA200506820B (sr)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
US20060257324A1 (en) * 2000-05-22 2006-11-16 Chiesi Farmaceutici S.P.A. Pharmaceutical solution formulations for pressurised metered dose inhalers
JP2007500676A (ja) * 2003-07-31 2007-01-18 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 抗コリン作用薬とベータ受容体刺激薬を含む吸入用薬剤
JP2007501194A (ja) * 2003-08-05 2007-01-25 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ステロイドとβ模倣薬を含む吸入用薬剤
PT1670482E (pt) 2003-09-16 2014-03-12 Takeda Gmbh Utilização de ciclesonida para o tratamento de doenças respiratórias
WO2006097250A1 (en) * 2005-03-16 2006-09-21 Meda Pharma Gmbh & Co Kg The combination of anticholinergics and leukotriene recptor antagonists for the treatment of repiratory diseases
US20090298802A1 (en) * 2005-03-30 2009-12-03 Sequeira Joel A Pharmaceutical Compositions
AU2006275137A1 (en) * 2005-08-01 2007-02-08 Chiesi Farmaceutici S.P.A. Pharmaceutical formulations comprising a long-acting beta2-agonist for administration by nebulisation
WO2007058971A2 (en) 2005-11-10 2007-05-24 Bodor Nicholas S Soft anticholinergic esters
SI2098248T1 (sl) * 2005-12-21 2012-09-28 Meda Pharma Gmbh & Co Kg Kombinacija antiholinergikov, glukokortikoidov in beta-2-agonistov za zdravljenje vnetnih bolezni
CA2650813A1 (en) * 2006-05-24 2007-11-29 Boehringer Ingelheim International Gmbh New long-acting drug combinations for the treatment of respiratory diseases
EP1953143A1 (en) * 2007-01-30 2008-08-06 CHIESI FARMACEUTICI S.p.A. Process for the preparation of 8-hydroxy-5-[(1R)-1-hydroxy-2[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1H)-quinolinone monohydrochloride
MX2009008794A (es) * 2007-02-19 2009-08-25 Cipla Ltd Combinaciones farmaceuticas al menos de dos broncodilatadores o de un broncodilatador con un corticosteroide.
CA2709071C (en) 2007-12-14 2016-11-15 Labogroup S.A.S. Delivering aerosolizable food products
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2100598A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2309858A4 (en) * 2008-07-31 2011-09-14 Dekel Pharmaceuticals Ltd COMPOSITIONS AND METHOD FOR THE TREATMENT OF INFLAMMATORY DISEASES
WO2010097188A1 (en) * 2009-02-25 2010-09-02 Chiesi Farmaceutici S.P.A. Inhalation particles comprising a salt of carmoterol and a corticosteroid
BRPI1008165B1 (pt) * 2009-05-25 2020-02-27 Chiesi Farmaceutici S.P.A. Uma combinação terapêutica compreendendo um surfactante pulmonar e um esteróide
TWI792140B (zh) 2009-05-29 2023-02-11 美商沛爾醫療股份有限公司 用於經由呼吸道遞送二或更多種活性藥劑的組成物、方法與系統
AU2015201037C1 (en) * 2009-05-29 2017-07-27 Pearl Therapeutics, Inc. Respiratory delivery of active agents
EP2563364A1 (en) * 2010-04-26 2013-03-06 Mahmut Bilgic Combination of carmoterol and fluticasone for use in the treatment respiratory diseases
CN102247597B (zh) * 2010-05-19 2015-01-07 天津金耀集团有限公司 一种糖皮质激素与支气管扩张剂的吸入剂
RU2568882C2 (ru) * 2010-07-16 2015-11-20 Сипла Лимитед Фармацевтические композиции
WO2012010854A1 (en) 2010-07-23 2012-01-26 Cipla Limited Inhalation formulations comprising carmoterol in combination with a corticosteroid
CN102416179B (zh) * 2010-09-28 2014-05-07 益得生物科技股份有限公司 用于哮喘的吸入性复方组合物
TWI399202B (zh) * 2011-03-17 2013-06-21 Intech Biopharm Ltd 製備用於治療呼吸道疾病之定量噴霧吸入劑的製程方法
EP2510928A1 (en) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients
WO2014140648A1 (en) * 2013-03-15 2014-09-18 Verona Pharma Plc Drug combination
EP3193862B1 (en) 2014-09-16 2023-10-18 Igc Pharma Ip, Llc Topical cannabinoid composition for treating arthritic pain
PL3223807T3 (pl) 2014-11-24 2022-01-03 The Board Of Trustees Of The University Of Illinois Metoda zapobiegania lub leczenia choroby lub stanu płuc
WO2016118391A1 (en) 2015-01-25 2016-07-28 India Globalization Capital, Inc. Composition and method for treating seizure disorders
WO2017027651A1 (en) * 2015-08-12 2017-02-16 India Globalization Capital, Inc. Method and composition for treating cachexia and eating disorders
CA3027862A1 (en) 2016-06-15 2017-12-21 India Globalization Capital, Inc. Method and composition for treating seizure disorders
CN115337311B (zh) * 2022-09-26 2023-05-09 南京恒道医药科技股份有限公司 一种治疗呼吸系统疾病的组合物及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874063A (en) * 1991-04-11 1999-02-23 Astra Aktiebolag Pharmaceutical formulation
SE9700135D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
EP2036544B1 (en) * 1997-03-20 2016-12-28 Merck Sharp & Dohme Corp. Dosage form of powder agglomerates
IT1303788B1 (it) * 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
US20020081266A1 (en) * 1999-08-20 2002-06-27 Norton Healthcare Ltd. Spray dried powders for pulmonary or nasal administration
PE20011227A1 (es) * 2000-04-17 2002-01-07 Chiesi Farma Spa Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
WO2001089480A1 (en) * 2000-05-22 2001-11-29 Chiesi Farmaceutici S.P.A. Stable pharmaceutical solution formulations for pressurised metered dose inhalers
EP1340492A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Aerosol formulations for pulmonary administration of medicaments having systemic effects
PT1480615E (pt) * 2002-03-01 2010-06-16 Chiesi Farma Spa Formulação superfina de formoterol
EP1595531A1 (en) * 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers

Also Published As

Publication number Publication date
CN100370986C (zh) 2008-02-27
MXPA05009007A (es) 2005-10-18
PL377814A1 (pl) 2006-02-20
MEP32208A (en) 2010-10-10
TNSN05186A1 (en) 2007-06-11
SI1603565T1 (sl) 2008-10-31
ATE401887T1 (de) 2008-08-15
NZ541997A (en) 2008-12-24
MA27630A1 (fr) 2005-11-01
PT1603565E (pt) 2008-10-06
EP1834643A3 (en) 2007-10-24
DK1603565T3 (da) 2008-11-10
AU2004216472A1 (en) 2004-09-10
JP2006519204A (ja) 2006-08-24
ES2309503T3 (es) 2008-12-16
EP1603565A1 (en) 2005-12-14
NO20053959D0 (no) 2005-08-25
SA04250122B1 (ar) 2009-03-11
ZA200506820B (en) 2006-11-29
DE602004015260D1 (de) 2008-09-04
CA2517321A1 (en) 2004-09-10
EA200501108A1 (ru) 2006-04-28
HK1087009A1 (en) 2006-10-06
EP1603565B1 (en) 2008-07-23
CN101244063A (zh) 2008-08-20
BRPI0408047A (pt) 2006-02-14
AU2004216472B2 (en) 2009-08-06
CY1108360T1 (el) 2014-02-12
RS20050615A (en) 2007-09-21
HRP20050726A2 (en) 2006-02-28
WO2004075896A1 (en) 2004-09-10
AR043419A1 (es) 2005-07-27
EA008828B1 (ru) 2007-08-31
KR20050104367A (ko) 2005-11-02
US20070020190A1 (en) 2007-01-25
EP1452179A1 (en) 2004-09-01
CN1753678A (zh) 2006-03-29
PE20050290A1 (es) 2005-05-26
EP1834643A2 (en) 2007-09-19
UA82217C2 (uk) 2008-03-25

Similar Documents

Publication Publication Date Title
NO20053959L (no) Medikament omfattende hoy-aktiv langtidsvarende beta-2-aqonist i kombinasjon med andre aktive bestanddeler
EA200300776A1 (ru) Производные фенэтаноламина для лечения респираторных заболеваний
SG169233A1 (en) Pharmaceutical compositions comprising apomorphine for pulmonary inhalation
EA200500902A1 (ru) Порошковые лекарственные средства, содержащие соль тиотропия и ксинафоат салметерола
ES2187300A1 (es) Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos.
HUP0402075A2 (hu) Készítmények nátha kezelésére
HUP0401614A2 (hu) PDE4 inhibitort és antikolinerg hatóanyagot tartalmazó gyógyszerkészítmények és alkalmazásuk
EA200501105A1 (ru) Фармацевтическая композиция
HUP0402304A2 (hu) Deutériummal helyettesített dihidrofuranonszármazékok és azokat tartalmazó gyógyszerkészítmények
CA2519679A1 (en) Synergistic combination comprising roflumilast and an anticholinergic agent selected from ipratropium, oxitropium and tiotropium salts for the treatment of respiratory diseases
HUP0400222A2 (hu) PDE-4 inhibitort és H1 receptor antagonistát tartalmazó kombináció és ennek alkalmazása tüdőbetegségek kezelésére alkalmas gyógyszerkészítmény előállítására
SG149876A1 (en) Novel tiotropium salts, methods for the production thereof, and pharmaceutical formulations containing the same
JP4377564B2 (ja) 内服用組成物
NO20053023L (no) Synergistisk kombinasjon omfattende roflumilas og (R,R)-formoterol
EA200500864A1 (ru) Новый, содержащий тиотропий порошковый препарат для ингаляции
HUP0402062A2 (hu) Alkanoil-L-karnitin alkalmazása merevedési zavar kezelésére és ezt tartalmazó gyógyszerkészítmények
DE60308497D1 (de) Pulverzubereitungen zur inhalation
Eccles Over the counter medicines for colds
AU672022B2 (en) Antiviral combinations
BR112023002778A2 (pt) Ácido (1r,3s)-3-((5-ciano-4-feniltiazol-2-il) carbamoil) ciclopentano-1-carboxílico e derivados do mesmo para uso no tratamento de doenças das vias aéreas
TH77905B (th) ยาชนิดใหม่ซึ่งประกอบรวมด้วย (เบตา)2 -อะโกนิสต์ที่มีการออกฤทธิ์นาน และมีศักยภาพสูงในการใช้ร่วมกับส่วนประกอบออกฤทธิ์อื่นๆ
PT1490049E (pt) Citalopram para o tratamento da pre3ssao sanguinia elevada.
TH77905A (th) ยาชนิดใหม่ซึ่งประกอบรวมด้วย เบตา2 -อะโกนิสต์ที่มีการออกฤทธิ์นาน และมีศักยภาพสูงในการใช้ร่วมกับส่วนประกอบออกฤทธิ์อื่นๆ
CA2140237A1 (en) Antiviral combinations
JP2001089375A (ja) 感冒用組成物

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application